There is a another new weight loss drug on the horizon called Qnexa. This drug is a combination of two medications, phentermine and topiramate. It has been tested in clinical trials in 4500 subjects and has shown a 10.4-11% weight loss over a year versus 1.6-1.8% that took the placebo. 70% of the subjects taking the drug lost at least 5% of their body weight . The drug works in two ways to impact eating – through appetite and satiety. Although not available yet, it might prove to be a valuable tool in the treatment of obesity.
For some people , the use of weight loss medications is another method to help with controlling their excess weight. At CONCI, each patient is individually evaluated medically to make sure that he/she is an appropriate candidate for the treatment. The use of weight loss medications should always be part of a comprehensive weight management program to insure the best possible outcomes of treatment.